News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Immune Oncology
Breast Oncology
Gastrointestinal Oncology
Lung Oncology
Hematology
Radiotherapy
Cancer Types
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025

OncoDaily GI
OncoDaily Breast
OncoDaily IO
OncoDaily Lung
OncoDaily RT
OncoDaily GU
OncoDaily AI
OncoDaily Biotech

Services
Privacy Policy
Contact Us

Aug / 2026

August 2026
M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

« Jul

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
Events By OncoDaily
OncoGrants
OncoDaily TV
NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Community Oncology Global Congress 2026

Community Oncology Global Congress 2026

Donald Trump Nominates Heidi Overton as Next FDA Commissioner

Donald Trump Nominates Heidi Overton as Next FDA Commissioner

From the Marathon 2024 to Olympus 2026: ELPIDA Climbs for Children with Cancer Around the World

From the Marathon 2024 to Olympus 2026: ELPIDA Climbs for Children with Cancer Around the World

DART-PHASER: Daily Adaptive Salvage Radiotherapy in Prostate Cancer

DART-PHASER: Daily Adaptive Salvage Radiotherapy in Prostate Cancer

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

ctDNA and MRD in NSCLC: Emerging Clinical Applications in the Immunotherapy Era

Pancreatic Cancer FDA Approval Following Landmark Trial Led by Dana-Farber

Pancreatic Cancer FDA Approval Following Landmark Trial Led by Dana-Farber

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

ASCO 2026 Guideline: A Risk-Adapted Framework for Early HR-Positive, HER2-Negative Breast Cancer

Giannis Mountzios: A New ESMO Guide for Thoracic Cancer Care

Giannis Mountzios: A New ESMO Guide for Thoracic Cancer Care

OncoCalendar

Paris

Aug 28 • 1:11 PM

Google Calendar
iCalendar
Outlook 365
Outlook Live

Details

Date: Aug 28
Time:
1:11 PM

Venue

Paris
Paris, Île-de-France France + Google Map

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer Breast Cancer cancer care ASCO fight against cancer Lung cancer Global fight against cancer Cancer research Headlines immunotherapy ESMO NSCLC cancer treatment MD Anderson Cancer Center clinical trials cancer awareness colorectal cancer prostate cancer FDA Research Childhood Cancer UICC AACR ASCO24 chemotherapy Pancreatic Cancer radiation oncology Dana-Farber Cancer Institute American Cancer Society Robert Orlowski AI American Society of Clinical Oncology SIOP European Cancer Organisation NCI Precision Oncology National Cancer Institute Myeloma Paper of the Day WHO cervical cancer Paolo Tarantino Myeloma radiotherapy Vivek Subbiah IASLC multiple myeloma bladder cancer Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}